Publication Details
Abstract
This research aims to explore the design and application of prodrugs as an effective strategy in drug development. Prodrugs are chemically modified compounds designed to improve stability, solubility, and permeability, which are activated through enzymatic or chemical processes. This study reviews various types of prodrugs, including bioprecursors, targeted, mixed, and mutual prodrugs. The methods used in this research involve literature analysis and case studies focusing on prodrugs that have successfully enhanced bioavailability and therapeutic efficacy. The results indicate that the prodrug strategy can significantly overcome pharmacokinetic and pharmacodynamic limitations of drugs, extend the duration of effects, and improve target selectivity. The conclusion of this research confirms that prodrug design is a promising approach in enhancing modern drug therapy, particulaly in the context of cancer treatment.